Are Venlon Enterprises Ltd latest results good or bad?

Feb 14 2026 07:41 PM IST
share
Share Via
Venlon Enterprises Ltd's latest Q2 FY26 results show a mixed picture: while net sales increased by 57.76% sequentially to ₹2.54 crores, the company still reported a net loss of ₹0.46 crores and has faced persistent challenges, including negative operating margins and a deeply negative return on equity. Overall, the financial health remains precarious despite some signs of recovery.
Venlon Enterprises Ltd's latest financial results for Q2 FY26 reflect a complex operational landscape characterized by both challenges and some signs of recovery. The company reported net sales of ₹2.54 crores, which represents a significant sequential increase of 57.76% from the previous quarter's ₹1.61 crores. However, this recovery comes after a notable decline of 42.70% in Q1 FY26, indicating ongoing volatility in revenue generation. Year-on-year, revenue has contracted by 18.33% compared to ₹3.11 crores in Q2 FY25, highlighting persistent demand challenges in the commodity chemicals sector.
On the profitability front, Venlon recorded a net loss of ₹0.46 crores in Q2 FY26, which is an improvement of 53.54% from a loss of ₹0.99 crores in Q1 FY26. Despite this reduction in losses, the company continues to struggle with negative operating margins, which stood at -1.97%, although this is a marked improvement from the -29.81% margin in the prior quarter. This suggests that while there is some operational stabilization, the company is still unable to achieve sustainable profitability. The return on equity (ROE) remains deeply negative at -181.71%, indicating significant challenges in generating returns for shareholders. The company’s financial trajectory shows a pattern of persistent losses, with seven consecutive quarters of negative results, raising concerns about its long-term viability. In terms of evaluation, Venlon Enterprises Ltd experienced an adjustment in its evaluation, reflecting the ongoing operational difficulties despite some sequential improvements. The financial data indicates that while there are signs of recovery in revenue and a reduction in net losses, the overall financial health remains precarious, with significant operational challenges and a negative book value per share. The company must demonstrate consistent operational improvements to regain investor confidence and navigate its current financial landscape.
{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News